檢索結果 - Liu, Huaxiang
- Showing 1 - 17 results of 17
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis 由 Yuan, Min, Wang, Shujun, Yu, Lijie, Qu, Bo, Xu, Liming, Liu, Lining, Sun, Huanxia, Li, Chunxian, Shi, Yanjun, Liu, Huaxiang
出版 2017Text -
12
Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials 由 Sholter, Dalton, Wu, Jianmin, Jia, Bochao, Zhang, Hong, Griffing, Kirstin, Birt, Julie, Reis, Paulo Jorge Simoes, Liu, Huaxiang, Bingham, Clifton O.
出版 2022Text -
13
Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study 由 Zeng, Xiaofeng, Liu, Ju, Liu, Xiumei, Wu, Lijun, Liu, Yi, Liao, Xiangping, Liu, Huaxiang, Hu, Jiankang, Lu, Xin, Chen, Linjie, Xu, Jian, Jiang, Zhenyu, Lu, Fu-ai, Wu, Huaxiang, Li, Ying, Wang, Qingyu, Zhu, Jun
出版 2022Text -
14
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter,... 由 Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
出版 2020Text -
15
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points 由 Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
出版 2020Text -
16
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study 由 Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
出版 2021Text -
17
Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China 由 Liu, Xiaoqing, Zhang, Lifan, Zhang, Fengchun, Zeng, Xiaofeng, Zhao, Yan, Wang, Qian, Liu, Shengyun, Zuo, Xiaoxia, Zhang, Zhiyi, Wu, Huaxiang, Chen, Sheng, Li, Hongbin, Zhu, Ping, Wu, Lijun, Qi, Wencheng, Liu, Yi, Zhang, Miaojia, Liu, Huaxiang, Xu, Dong, Zheng, Wenjie, Zhang, Yueqiu, Shi, Xiaochun, Han, Lishuai, Zhou, Yaou, Zhao, Yanping, Wang, Wenwen, Li, Ting, Tie, Ning, Zhang, Kui, Luo, Cainan, Gong, Baoqi, Zhao, Yi, Lv, Chengyin, Song, Lijun, Wu, Qingjun, Fei, Yunyun, Zhang, Lei, Luo, Hui, Sun, Jiaying, Xue, Jing, Gu, Liyang, Wang, Jing, Han, Qing, Yimaity, Kuerbanjiang, Zhou, Jiaxin, Zhao, Lidan, Bian, Sainan, Qi, Wufang, Li, Yanhong, Zhu, Yujing, Han, Huijun, Liao, Susu, Liu, Gaifen
出版 2021Text